Roche Malaysia has announced that the National Pharmaceutical Regulatory Agency (NPRA) in Malaysia has approved Evrysdi™ (risdiplam) for the treatment of spinal muscular atrophy (SMA) in adults and children two months and older.
HEY! I Am Charmaine Pua, A Malaysian Lifestyle Blogger.
Day dreamer ♥ Sensitive and compassionate by nature ♥ Live for romance ♥ Love to share
